Subscribe to RSS
DOI: 10.1055/s-2004-815439
HIV Protease Inhibitors Part 2: [3+2] Cycloaddition, Isomerization; and Ring Expansion en route to 4,5-Substituted Cyclohexenones
Publication History
Publication Date:
29 January 2004 (online)
Abstract
4,5-Substituted cyclohexanone 10 and its derivatives are carbocyclic analogues of Indinavir 3 and are expected to have antiviral activity. Early attempts to obtain these compounds via a diastereoselective [3+2] cycloaddition between 19 and 14 failed due to the sensitivity of the cycloadduct 24. It proved possible to obtain 30 from the α,β-unsaturated ester 27: [3+2] cycloaddition, isomerization, and ring expansion provided α,β-unsaturated ketone 31 from ester 26 in good yields. Further transformations of 31 gave the hydroxyethylamino inhibitor analogues of Indinavir 3.
Key words:
[3+2] cycloaddition - cyclopentene - ring expansion - cyclohexenone - HIV protease inhibitor
- 2
Crackett P.Demont E.Eatherton A.Frampton CS.Gilbert J.Kahn I.Redshaw S.Watson W. Synlett 2004, DOI: 10.1055/s-2004-81548 - 3
Martin VA.Murray DH.Pratt NE.Zhao Y.Albizati KF. J. Am. Chem. Soc. 1990, 112: 6965 - 4
Nicolaou KC.Postema Maarten HD.Miller ND.Yang G. Angew. Chem. Int. Ed. 1997, 36: 2821 -
5a
Adam W.Hadjiarapoglou L.Wang X. Tetrahedron Lett. 1989, 30: 6497 -
5b
Stankovic S.Espenson JH. J. Org. Chem. 1998, 63: 4129 -
6a For an example of selective deprotonation of non-symmetrical ketones using a chiral amide base see:
Sobukawa M.Nakajima M.Koga K. Tetrahedron: Asymmetry 1990, 1: 295 -
6b For a recent review on the use of chiral amide bases see:
O’Brien P. J. Chem. Soc., Perkin Trans. 1 1998, 1439 ; and references therein - 7
Overberger CG.Marullo NP.Hiskey RG. J. Am. Chem. Soc. 1961, 83: 1374 - 8
Ghera E.Yechezkel T.Hassner A. J. Org. Chem. 1996, 61: 4959 - 9
Parkes KEB.Bushnell DJ.Crackett PH.Dunson SJ.Freeman AC.Gunn MP.Hopkins RA.Lambert RW.Martin JA.Merrett JH.Redshaw S.Spurden WC.Thomas GJ. J. Org. Chem. 1994, 59: 3656 - 10
Yamagushi M.Hirao I. Tetrahedron Lett. 1983, 24: 391-394 - 11 Use of propiolate trialkylester could have avoided obtaining this by-product but the large scale synthesis of these compounds was considered difficult. See for example:
Baldwin JE.Pritchard GJ.Rathmell RE. Synth. Commun. 2000, 30: 3833 - For the procedures used to synthesize 17 see:
-
12a
Brimble MA.Edmonds MK.Williams GM. Tetrahedron 1992, 48: 6455 -
12b
Marshall JA.Andrews RC.Lebioda L. J. Org. Chem. 1987, 52: 2378 - 13 This type of compound can be obtained by olefin metathesis but the high dilution of these reaction is not compatible with the scale of reaction envisioned in this synthesis, see:
Ghosh AK.Cappiello J.Shin D. Tetrahedron Lett. 1998, 39: 4651 - 14
Plummer JS.Emery LA.Stier MA.Suto MJ. Tetrahedron Lett. 1993, 34: 7529 - 15
Lakshmipathi P.Rama Rao AV. Tetrahedron Lett. 1997, 38: 2551 - 17 SmI2 does not usually reduce ester. See
Molander GA. Org. React. 1994, 46: 211-367 ; and references cited therein - 18
Kukojla S.Lammert SR. J. Am. Chem. Soc. 1975, 97: 5583 - An other approach was attempted using literature precedent, see:
-
19a
Hanessian S.Haeil P.Rui-Yang Y. Synlett 1997, 353 -
19b
Nicoll-Griffith DA.Weiler L. Tetrahedron 1991, 47: 2733 - 20
N,N-Dibenzyl amine was considered to be a reasonable solution. For an excellent review on N,N-dibenzylamino compounds see:
Reetz MT. Chem. Rev. 1999, 99: 1121 - 23
Gemal AL.Luche J.-L. J. Am. Chem. Soc. 1981, 103: 5454
References
Present address: GlaxoSmithKline. The Frythe, Welwyn, AL6 9AR Hertfordshire, UK.
16CCDC No. 217035 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge via www.ccdc.cam.ac.uk/conts/retrieving.html (or from the CCDC 12 Union Road Cambridge CB2 1EZ UK; fax:+44 1223 336033; e-mail: deposit@ccdc.cam.ac.uk)
21The reaction of 14 with oxazolidinone 4 was non-selective. Adduct 28 was obtained as a 1:1 mixture of trans-isomers.
22The direct reduction of allylic sulfone 28 gave a mixture of alkenes.